Condition
MASH With Fibrosis
Total Trials
5
Recruiting
4
Active
5
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 3 (1)
Trial Status
Recruiting4
Active Not Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06215716Phase 3Recruiting
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NCT06588699Phase 2Recruiting
Digoxin In NASH (CODIN)
NCT07185334Not ApplicableActive Not Recruiting
Single-Stage Prepectoral Placement of Textured Implants Using a Polyester Mesh Endoprostheses With Fluoropolymer Coating in Patients With Breast Cancer
NCT07013916Not ApplicableRecruiting
Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
NCT05651724Recruiting
Global Research Initiative for Patients Screening on MASH
Showing all 5 trials